These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29174373)

  • 1. Sara Lustigman: Developing a vaccine to accelerate onchocerciasis elimination.
    Trends Parasitol; 2018 Jan; 34(1):1-3. PubMed ID: 29174373
    [No Abstract]   [Full Text] [Related]  

  • 2. African Programme for Onchocerciasis Control: progress report, 2013-2014.
    Wkly Epidemiol Rec; 2014 Dec; 89(49):551-60. PubMed ID: 25485343
    [No Abstract]   [Full Text] [Related]  

  • 3. Establishing quality assured (QA) laboratory support for onchocerciasis elimination in Africa.
    Shott J; Ducker C; Unnasch TR; Mackenzie CD
    Int Health; 2018 Mar; 10(suppl_1):i33-i39. PubMed ID: 29471345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions.
    Colebunders R; Stolk WA; Siewe Fodjo JN; Mackenzie CD; Hopkins A
    Infect Dis Poverty; 2019 Oct; 8(1):83. PubMed ID: 31578157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onchocerciasis elimination in sub-Saharan Africa requires alternative strategies.
    Njamnshi AK; Njamnshi WY; Siewe Fodjo JN
    Lancet Glob Health; 2024 May; 12(5):e715-e716. PubMed ID: 38484746
    [No Abstract]   [Full Text] [Related]  

  • 6. Elimination of onchocerciasis from Africa: possible?
    Mackenzie CD; Homeida MM; Hopkins AD; Lawrence JC
    Trends Parasitol; 2012 Jan; 28(1):16-22. PubMed ID: 22079526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala.
    Wkly Epidemiol Rec; 2016 Oct; 91(43):501-5. PubMed ID: 27801556
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of national committees in eliminating onchocerciasis.
    Griswold E; Unnasch T; Eberhard M; Nwoke BEB; Morales Z; Muheki Tukahebwa E; Kebede B; Anagbogu I; Katabarwa M; Habomugisha P; Tadesse Z; Miri ES; Evans D; Cohn D; Elhassan E; Richards F
    Int Health; 2018 Mar; 10(suppl_1):i60-i70. PubMed ID: 29471337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investing in justice: ethics, evidence, and the eradication investment cases for lymphatic filariasis and onchocerciasis.
    Bailey TC; Merritt MW; Tediosi F
    Am J Public Health; 2015 Apr; 105(4):629-36. PubMed ID: 25713967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time.
    Evans DS; Unnasch TR; Richards FO
    Lancet; 2015 May; 385(9983):2151-2. PubMed ID: 26068266
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress report on the elimination of human onchocerciasis, 2015-2016.
    Wkly Epidemiol Rec; 2016 Oct; 91(43):505-14. PubMed ID: 27801998
    [No Abstract]   [Full Text] [Related]  

  • 12. 681 Progress report on the elimination of human onchocerciasis, 2016–2017.
    Wkly Epidemiol Rec; 2017 Nov; 92(45):681-94. PubMed ID: 29130679
    [No Abstract]   [Full Text] [Related]  

  • 13. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
    Coffeng LE; Stolk WA; Hoerauf A; Habbema D; Bakker R; Hopkins AD; de Vlas SJ
    PLoS One; 2014; 9(12):e115886. PubMed ID: 25545677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful elimination of onchocerciasis (river blindness) vectors from isolated foci in two African countries.
    Brattig NW
    Acta Trop; 2009 Sep; 111(3):201-2. PubMed ID: 19619685
    [No Abstract]   [Full Text] [Related]  

  • 15. The onchocerciasis chronicle: from the beginning to the end?
    Crump A; Morel CM; Omura S
    Trends Parasitol; 2012 Jul; 28(7):280-8. PubMed ID: 22633470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Tools for Onchocerciasis Elimination Programs.
    Vlaminck J; Fischer PU; Weil GJ
    Trends Parasitol; 2015 Nov; 31(11):571-582. PubMed ID: 26458784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2012.
    Wkly Epidemiol Rec; 2012 Dec; 87(49/50):494-502. PubMed ID: 23311005
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
    Duerr HP; Eichner M
    Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whither onchocerciasis control in Africa?
    Hopkins DR; Richards FO; Katabarwa M
    Am J Trop Med Hyg; 2005 Jan; 72(1):1-2. PubMed ID: 15728857
    [No Abstract]   [Full Text] [Related]  

  • 20. Cross-border issues: an important component of onchocerciasis elimination programmes.
    Bush S; Sodahlon Y; Downs P; Mackenzie CD
    Int Health; 2018 Mar; 10(suppl_1):i54-i59. PubMed ID: 29471344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.